The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial. - Fisk, Marie; Cheriyan, Joseph; Mohan, Divya; Forman, Julia; Mäki-Petäjä, Kaisa M.; McEniery, Carmel M.; Fuld, Jonathan; Rudd, James H. F.; Hopkinson, Nicholas S.; Lomas, David A.; Cockcroft, John R.; Tal-Singer, Ruth; et al. (PLoS ONE, 2018)